These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 346041)

  • 21. [Value of cutaneous immunofluorescence in the etiological diagnosis of a disease with antinuclear antibodies].
    Lévêque E; Dréno B; Planchon B; Bureau B; Litoux P; Barrière H
    Ann Dermatol Venereol; 1986; 113(8):655-64. PubMed ID: 3541758
    [No Abstract]   [Full Text] [Related]  

  • 22. Direct immunofluorescence patterns in clinically healthy skin of patients with collagen diseases.
    Velthuis PJ; Kater L; Baart de la Faille H
    Clin Dermatol; 1992; 10(4):423-30. PubMed ID: 1303807
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 24. The immunofluorescent "band" test in mixed connective tissue disease.
    Levitin PM; Weary PE; Giuliano VJ
    Ann Intern Med; 1975 Jul; 83(1):53-5. PubMed ID: 1096702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct and indirect immunofluorescent findings in dermatomyositis.
    Chen Z; Maize JC; Silver RM; Dobson RL; Maricq HR; Ainsworth SK
    J Cutan Pathol; 1985 Feb; 12(1):18-27. PubMed ID: 3919071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of immunofluorescence at the dermal/epidermal junction in connective tissue disorders.
    Langlands DR; Dawkins RL
    Aust N Z J Med; 1978; 8 Suppl 1():87-9. PubMed ID: 365161
    [No Abstract]   [Full Text] [Related]  

  • 28. Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.
    Shu S; Provost T; Croxdale MB; Reichlin M; Beutner EH
    Clin Exp Immunol; 1977 Feb; 27(2):238-44. PubMed ID: 300310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic lupus erythematosus. Studies of the antibodies bound to skin.
    Landry M; Sams WM
    J Clin Invest; 1973 Aug; 52(8):1871-80. PubMed ID: 4578295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: should Graves' disease be considered a collagen disorder?
    Kiljanski JI; Peele K; Stachura I; Pickeral J; Stolarski C; Kennerdell JS; Wall JR
    J Endocrinol Invest; 1997 Nov; 20(10):585-91. PubMed ID: 9438915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo antinuclear antibody of the skin: diagnostic significance and association with selective antinuclear antibodies.
    Velthuis PJ; Kater L; van der Tweel I; Meyling FG; Derksen RH; Hené RJ; van Geutselaar JA; Baart de la Faille H
    Ann Rheum Dis; 1990 Mar; 49(3):163-7. PubMed ID: 2181945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA.
    Kallenberg CG; de Jong MC; Walstra TM; Kardaun S; The TH
    J Rheumatol; 1983 Oct; 10(5):733-40. PubMed ID: 6606041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin immunofluorescence patterns in SLE patients in Singapore.
    Ratnam KV; Phay KL; Ng SK; Tan T
    Singapore Med J; 1987 Dec; 28(6):517-9. PubMed ID: 3327168
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methods for determining antinuclear antibodies and their clinical significance].
    Aeschlimann A; Meyer O; Kahn MF; Müller W
    Schweiz Med Wochenschr; 1989 Dec; 119(48):1701-12. PubMed ID: 2694362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The problem of slightly speckled cell nucleus reaction in the immunofluorescent technical analysis of antinuclear factors].
    Bäumer A; Brinkmann A
    Z Rheumaforsch; 1970; 29(9):264-9. PubMed ID: 4919618
    [No Abstract]   [Full Text] [Related]  

  • 37. [Descriptive and comparative study of technical methods used for the detection of antinuclear antibodies].
    Abuaf N
    Ann Biol Clin (Paris); 1982; 40(2):65-74. PubMed ID: 6812470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hidden anti-nuclear antibodies in rheumatic diseases.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1980 Feb; 39(2):538-43. PubMed ID: 6993073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3d,g is present in normal human epidermal basement membrane.
    Basset-Seguin N; Dersookian M; Cehrs K; Yancey KB
    J Immunol; 1988 Aug; 141(4):1273-80. PubMed ID: 3135326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinuclear antibodies and patterns of nuclear immunofluorescence in systemic lupus erythmatosus and other collagen vascular diseases.
    Bhuyan UN; Malaviya AN
    Indian J Med Res; 1976 Jun; 64(6):895-902. PubMed ID: 789235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.